• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Trends in testing and diagnosis of peripheral vascular disease in the US

Trends in testing and diagnosis of peripheral vascular disease in the US

by Truveta Research | Jul 25, 2024 | Research, Research Insights

The analysis was based on a sample of 17,501,982 patients from January 2018 to May 2024. During the study period, 9,271 patients were tested (using CPT code 93922) for the first time and had a diagnosis of peripheral vascular disease/peripheral artery disease...
Trends in PSA testing to screen for prostate-related conditions, including cancer

Trends in PSA testing to screen for prostate-related conditions, including cancer

by Truveta Research | Jun 10, 2024 | Research, Research Insights

There are mixed prostate-specific antigen (PSA) screening recommendations for men of varying ages. The objective of this study was to describe variation in first-time PSA values across demographic and SDOH factors. In a study of nearly 4 million men with PSA lab...
Real-world prescribing of lecanemab in the United States

Real-world prescribing of lecanemab in the United States

by Truveta Research | May 6, 2024 | Research, Research Insights

Authors: Brianna M. Goodwin Cartwright, MS ⊕Truveta, Inc, Bellevue, WA, Patricia J. Rodriguez, PhD MPH ⊕Truveta, Inc, Bellevue, WA, Samuel Gratzl, PhD ⊕Truveta, Inc, Bellevue, WA, Charlotte Baker, DrPH MPH CPH ⊕Truveta, Inc, Bellevue, WA, Nicholas Stucky, MD PhD...
Baseline A1C and BMI trends for people with type 2 diabetes receiving first-time GLP-1 RA prescriptions

Baseline A1C and BMI trends for people with type 2 diabetes receiving first-time GLP-1 RA prescriptions

by Truveta Research | May 6, 2024 | Research, Research Insights

Authors: Brianna M. Goodwin Cartwright ⊕Truveta, Inc, Bellevue, WA, Patricia J. Rodriguez, PhD MPH ⊕Truveta, Inc, Bellevue, WA, Samuel Gratzl PhD ⊕Truveta, Inc, Bellevue, WA, Charlotte Baker DrPH MPH CPH ⊕Truveta, Inc, Bellevue, WA, Christopher M. Worsham, MD MPH...
Outcomes and disparities for patients with aortic stenosis, classified by echocardiogram data

Outcomes and disparities for patients with aortic stenosis, classified by echocardiogram data

by Truveta Research | Mar 6, 2024 | Research, Research Insights

Disparities in time to treatment and treatment outcomes exist for people with severe aortic stenosis receiving TAVR and SAVR procedures. We studied the rate of people who receive TAVR, SAVR, aortic valve repair, and aortic balloon valvuloplasty procedures and time to...
Using echocardiogram data to classify aortic stenosis severity

Using echocardiogram data to classify aortic stenosis severity

by Truveta Research | Feb 22, 2024 | Research, Research Insights

Aortic stenosis – the narrowing of the valve between the lower left heart chamber (left ventricle) and the aorta – is commonly diagnosed with an echocardiogram and staged according to the disease progression. However, it’s a difficult condition to study across large...
« Older Entries
Next Entries »

Share this


Recent posts

  • New study finds GLP-1 RA medications may significantly reduce risk of alcohol-related hospitalization
  • Understanding the impact of the COVID-19 pandemic on childhood MMR vaccination patterns
  • Shifting trends in TKA fixation: Real-world evidence on the changing landscape of cemented vs uncemented TKA

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Our website uses cookies to ensure you have the best experience.AcceptPrivacy notice